Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vivus Inc VVUSQ

Healthcare Biotechnology
VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic... see more

Recent & Breaking News (OTCPK:VVUSQ)

VIVUS Comments on Sam Colin's Questionable Claims

Globe Newswire June 25, 2013

First Manhattan Sends Letter to VIVUS Stockholders

Business Wire June 24, 2013

VIVUS Announces ADA Scientific Presentations

Globe Newswire June 21, 2013

VIVUS Announces AANP Scientific Presentations

Globe Newswire June 21, 2013

Five Star Equities Issues New Research Reports on ACI, NVDA, RHT and VVUS

Accesswire June 20, 2013

VIVUS Announces Study Results Showing STENDRA (Avanafil) is Effective for Sexual Activity Within 15 Minutes in Men With Erectile Dysfunction (ED)

Globe Newswire June 19, 2013

VIVUS Posts Investor Presentation

Globe Newswire June 19, 2013

Open Letter to Vivus Employees Released by First Manhattan Co.

Business Wire June 17, 2013

New Review Article Discusses Complications-Centric Approach to Obesity Medical Management With Qsymia

Globe Newswire June 17, 2013

VIVUS Urges Stockholders to Support the Board of Directors and Management Team at This Critical Time

Globe Newswire June 17, 2013

VIVUS Announces Scientific Presentations

Globe Newswire June 15, 2013

VIVUS to Present at Upcoming Investor Conference

Globe Newswire June 12, 2013

New Article Discusses Treatment Options for Weight Management in People With Type 2 Diabetes

Globe Newswire June 7, 2013

VIVUS Files Definitive Proxy Materials With SEC

Globe Newswire June 5, 2013

First Manhattan Mails Definitive Proxy Statement and Sends Letter to Vivus Stockholders

Business Wire June 4, 2013

Pre-Market Analysis on VVUS, SNY, XRAY, and ACUR

Accesswire June 4, 2013

VIVUS Announces Scientific Presentations

Globe Newswire June 3, 2013

Wall Street Fundamentals Releases New In-Depth Stock Reports on ARNA, MNKD, OREX and VVUS

Accesswire May 31, 2013

Free Research Reports on DOV, DRYS, PLCE and VVUS Issued by the Bedford Report

Marketwired May 24, 2013

First Manhattan Adds Alex Denner to Vivus Board Slate

Business Wire May 23, 2013